Evoke Pharma(EVOK) - 2023 Q4 - Earnings Call Transcript

Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2023 Results Conference Call March 14, 2024 4:30 PM ET Company Participants Daniel Kontoh-Boateng - Investor Relations David Gonyer - Co-Founder, CEO & Director Christopher Quesenberry - GIMOTI’s Chief Commercial Officer, EVERSANA Matthew D'Onofrio - Chief Business Officer Conference Call Participants Yale Jen - Laidlaw & Company Operator Good afternoon, and welcome to the Evoke Pharma Fourth Quarter and Full-Year 2023 Earnings Conference Call. Currently, all callers have ...